Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallach

Showing results (251-260 of 457) with videos related to

Pageof 46
Sort By:
JAMA Internal Medicine|January 18, 2018
Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015Alexander C Egilman, Joshua D Wallach, Joseph S Ross, et al.
JAMA Psychiatry|May 28, 2020
Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govJoshua D Wallach, John H Krystal, Joseph S Ross, et al.
Ecology Letters|June 16, 2010
Predator control promotes invasive dominated ecological statesArian D Wallach, Christopher N Johnson, Euan G Ritchie, et al.
Annales D'Immunologie|July 1, 1983
Mechanisms of T-cell unresponsiveness in leprosyM A Bach, A Hoffenbach, P H Lagrange, et al.
Dermatologica|January 1, 1986
Captopril-induced lichen planus pemphigoides with pemphigus-like features. A case reportB Flageul, C Foldes, D Wallach, et al.
Clinical Trials (London, England)|April 17, 2026
Surrogate markers used as efficacy endpoints in NIH-sponsored clinical trialsAyman Mohammad, Samuel Yoon, Joshua D Wallach, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this proteinT Hahn, L Toker, S Budilovsky, et al.
British Journal of Cancer|December 1, 1992
Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2D W Miles, D Aderka, H Engelmann, et al.
Journal of Chromatography|June 27, 1990
Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatographyD Novick, H Engelmann, D Wallach, et al.
Lancet (London, England)|November 23, 1985
Cachectin/tumour-necrosis-factor production by cancer patientsD Aderka, S Fisher, Y Levo, et al.
Pageof 46

Showing results (251-260 of 457) with videos related to

Sort By:
Pageof 46
JAMA Internal Medicine|January 18, 2018
Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015Alexander C Egilman, Joshua D Wallach, Joseph S Ross, et al.
JAMA Psychiatry|May 28, 2020
Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govJoshua D Wallach, John H Krystal, Joseph S Ross, et al.
Ecology Letters|June 16, 2010
Predator control promotes invasive dominated ecological statesArian D Wallach, Christopher N Johnson, Euan G Ritchie, et al.
Annales D'Immunologie|July 1, 1983
Mechanisms of T-cell unresponsiveness in leprosyM A Bach, A Hoffenbach, P H Lagrange, et al.
Dermatologica|January 1, 1986
Captopril-induced lichen planus pemphigoides with pemphigus-like features. A case reportB Flageul, C Foldes, D Wallach, et al.
Clinical Trials (London, England)|April 17, 2026
Surrogate markers used as efficacy endpoints in NIH-sponsored clinical trialsAyman Mohammad, Samuel Yoon, Joshua D Wallach, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this proteinT Hahn, L Toker, S Budilovsky, et al.
British Journal of Cancer|December 1, 1992
Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2D W Miles, D Aderka, H Engelmann, et al.
Journal of Chromatography|June 27, 1990
Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatographyD Novick, H Engelmann, D Wallach, et al.
Lancet (London, England)|November 23, 1985
Cachectin/tumour-necrosis-factor production by cancer patientsD Aderka, S Fisher, Y Levo, et al.
Pageof 46